clarification
I understand specifically that the "Abstract" to be published in the December issue of BLOOD... is to be released in the second or third week of November.
This "Abstract" will basically be the equivalent of a Scientific Press Release, outlining the statistically significant Clinical Results from the 1402 Trials. Bottom line, this should be market moving news... we dont have to wait til the actual conference to see the pertinent aspects of the trials.